Cannara Biotech Inc.

Listing Exchange:

CSE

Status:

Active

Industry:

Life Sciences

Symbol:

LOVE

CSE Index:

Currency:

Cannara Biotech Inc. is an emerging vertically integrated cannabis company building the largest indoor cannabis cultivation facility in Quebec, a modern and secure 625,000 square foot facility.

Leveraging Quebec’s low electricity costs, Cannara will produce premium indoor cannabis and derivative products for the Canadian and international markets.

Cannara Biotech Inc. (LOVE)

SEDAR Information

Company Info

Address

333, boul. Décarie

Suite 200

Montréal, QC H4N 3M9

Canada

Phone

514-543-4200

lennie@cannara.ca

Website

http://www.cannara.ca

Listing date

Monday, January 14, 2019

Transfer Agent

Computershare Investor Services Inc.

Capitalization

Issued & Outstanding:

706,970,705

Reserved for Issuance:

54,513,134

News Releases

27/05/2020

Cannara Proposes Agreement to Acquire Global shopCBD.com

15/05/2020

Cannara Biotech Inc. appoints Mary Durocher as New Board Director

Bulletins

11/01/2019

2019-0111 – New Listing - Cannara Biotech Inc. (LOVE)

le 11 janvier/January 2019

The common shares of Cannara Biotech Inc., have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Cannara Biotech Inc. is a vertically integrated cannabis company building the largest indoor cannabis cultivation facility in Quebec, a modern and secure 625,000 square foot facility.

Condensed Interim Consolidated Financial Statements for the three and six-month periods ended February 29, 2020 and February 28, 2019

CSE Filings

File	Type	Date
Form 7 - Monthly progress report April 2020	Monthly Progress Report	05/05/2020
Certification of Interim Filings CFO	Other	16/04/2020
Certification of Interim Filings CEO	Other	16/04/2020
MANAGEMENT DISCUSSION AND ANALYSIS for the three and six-month periods ended February 29, 2020 and February 28, 2019	MD&A (Management Discussion and Analysis)	16/04/2020
Condensed Interim Consolidated Financial Statements for the three and six-month periods ended February 29, 2020 and February 28, 2019	Interim Financial Statements	16/04/2020
Form 5 - Quarterly Listing Statement Q2 2020	Quarterly Listing Statement	16/04/2020
Form 7 - Monthly progress report February 2020	Monthly Progress Report	03/03/2020
Quarterly Listing Statement Q1 2020	Quarterly Listing Statement	23/01/2020
Quarterly Listing Statement Q4	Quarterly Listing Statement	08/01/2020

1
2
3
4
5
next ›
last »

Cannara Biotech Inc.

You are here

Cannara Biotech Inc. (LOVE)

SEDAR Information

Company Info

Capitalization

News Releases

Cannara Proposes Agreement to Acquire Global shopCBD.com

Cannara Biotech Inc. appoints Mary Durocher as New Board Director

Bulletins

2019-0111 – New Listing - Cannara Biotech Inc. (LOVE)

CSE Filings

Form 7 - Monthly progress report April 2020

Certification of Interim Filings CFO

Certification of Interim Filings CEO

MANAGEMENT DISCUSSION AND ANALYSIS for the three and six-month periods ended February 29, 2020 and February 28, 2019

Condensed Interim Consolidated Financial Statements for the three and six-month periods ended February 29, 2020 and February 28, 2019

Latest CSE News

Upcoming Events

Virtual Industry Updates: The Rise of the Psychedelics Sector

Investing in Psychedelics

Virtual Industry Updates: Tech Strikes Back

Connect with us:

You are here

Cannara Biotech Inc.

You are here

Cannara Biotech Inc. (LOVE)

SEDAR Information

Search form

Company Info

Capitalization

News Releases

News Releases

Bulletins

Bulletins

CSE Filings

CSE Filings

Latest CSE News

Upcoming Events

Connect with us: